A French biotech company has opened its U.S. headquarters in two patient rooms of a former Bellevue hospital while closing in on a $26 million funding round.
Strasbourg, France-based AdipoPharma has located in the former Allegheny General Hospital Suburban Campus, also home to the Innovation Works’ AlphaLab startup business accelerator opened last year.
The funding will take the pre-revenue company, which was founded in 2017 and employs fewer than 10 people, through phase two clinical trials of the company’s first drug — a treatment for type 2 diabetes, Chief Business Officer and Chairman James Nolan said.
Clinical trials are expected to start by the end of the year; phase two determines a product’s safety and efficacy in people.
“This is the best science I’ve ever worked with,” said Mr. Nolan, a Mount Washington native and 40-year veteran of the pharmaceutical industry who made the case that the company is bringing a new approach to diabetes treatment.
AdipoPharma’s drug, PATAS, is meant to treat insulin resistance, the root cause of type 2 diabetes.
Read More
Jeff Cohen, chief physician executive, community health at Allegheny Health Network, said there is plenty of room for AdipoPharma and other life science companies to grow in the former hospital, which features a commercial kitchen and fully equipped wet and dry labs.
He describes himself as a cheerleader for startups, adding that space is available in the building at below-market rates.
“Innovation happens at many different places and in many different ways,” Dr. Cohen said. “Don’t go building megaspaces; keep your costs in line and you’ll be fine.”
Kris B. Mamula: kmamula@post-gazette.com






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.